NYSE · Medical Devices · USD
Inspire Medical Systems, Inc. (INSP) Stock Analysis
Inspire Medical Systems, Inc. (INSP) is a Medical Devices stock listed on NYSE and quoted in US Dollar.
Price History
No price data available
Hover for the daily close. The dotted line marks the period open.
INSP Key Statistics
As of Sep 4, 2026Trading
- Open
- $61.00
- Previous Close
- $62.14
- Day's Range
- 60.00–63.43
- 52-Week Range
- 38.91–147.03
- Volume
- 425.70K
- BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
- 0.70
Valuation
- Market Cap
- $1.82B
- P/E Ratio
- 13.71
- Forward P/EShare price divided by forecast earnings for the year ahead, rather than the year just past.
- 41.04
- P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
- 2.03
- EPS (ttm)Profit attributable to each share over the last twelve months.
- 4.60
Financials (FY)
- Revenue (FY)
- $911.98M+13.60%
- Net Income (FY)
- $145.42M+171.77%
- Profit marginThe share of revenue left as profit after all costs and taxes.
- 15.03%
- Shares Outstanding
- 28.91M
- 1-Year Return
- −26.92%
Dividend and dates
- Earnings Date
- November 2, 2026estimated
- Avg Volume
- 841.26K
Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.
INSP Stock Return by Calendar Year
Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.
| Year | Return |
|---|---|
| 2026 (partial year) | −31.61% |
| 2025 | −50.25% |
| 2024 | −8.87% |
| 2023 | −19.24% |
| 2022 | +9.48% |
| 2021 | +22.31% |
| 2020 | +153.46% |
| 2019 | +75.64% |
| 2018 (partial year) | +69.14% |
As of September 4, 2026.
INSP Revenue and Earnings by Fiscal Year
FY ends December| Fiscal year | Revenue | Net income | Net margin |
|---|---|---|---|
| 2025 | $911.98M | $145.42M | 15.9% |
| 2024 | $802.80M | $53.51M | 6.7% |
| 2023 | $624.80M | −$21.15M | −3.4% |
| 2022 | $407.86M | −$44.88M | −11.0% |
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Net margin |
|---|---|---|---|---|---|
| 2025 | $911.98M | $778.76M | $50.95M | $145.42M | 15.9% |
| 2024 | $802.80M | $679.82M | $36.08M | $53.51M | 6.7% |
| 2023 | $624.80M | $528.22M | −$40.27M | −$21.15M | −3.4% |
| 2022 | $407.86M | $341.74M | −$47.59M | −$44.88M | −11.0% |
Annual figures as reported, in the company's reporting currency. As of December 31, 2025.
INSP Valuation vs Medical Devices Median
Median of 151 stocks| Metric | INSP | Medical Devices median | vs median |
|---|---|---|---|
| P/E | 13.71 | 26.80 | 49% below |
| P/S ratio | 2.03 | 2.98 | 32% below |
| Profit margin | 15.03% | −1.69% | 16.7 pts above |
Medians across 151 Medical Devices stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.
Recent News
Inspire Medical Systems (INSP): Buy, Sell, or Hold Post Q2 Earnings?
YahooWhy Is Inspire (INSP) Down 4.1% Since Last Earnings Report?
YahooInspire Medical Systems, Inc. 2026 Q2 - Results - Earnings Call Presentation
SeekingAlphaOppenheimer Upgrades Inspire Medical Systems (INSP)
FintelJP Morgan Maintains Neutral on Inspire Medical Systems, Raises Price Target to $60
BenzingaMizuho Maintains Outperform on Inspire Medical Systems, Raises Price Target to $65
Benzinga
All 15 articles ↓Show fewer ↑
Oppenheimer Upgrades Inspire Medical Systems to Outperform, Announces $85 Price Target
BenzingaTruist Securities Reiterates Hold on Inspire Medical Systems, Raises Price Target to $62
BenzingaInspire Medical Systems (INSP) Price Target Decreased by 10.76% to 62.63
FintelEvercore ISI Group Maintains In-Line on Inspire Medical Systems, Raises Price Target to $54
BenzingaInspire Medical Systems Analysts Raise Their Forecasts Following Strong Q2 Results
BenzingaPiper Sandler Maintains Neutral on Inspire Medical Systems, Raises Price Target to $60
BenzingaBaird Maintains Neutral on Inspire Medical Systems, Raises Price Target to $59
BenzingaInspire Medical Systems, Inc. (INSP) Q2 2026 Earnings Call Transcript
SeekingAlphaUBS Assumes Inspire Medical Systems at Sell, Lowers Price Target of $39
Benzinga
News provided by third-party sources. Not financial advice.
Analysis
Data-derivedEvery figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of September 4, 2026.
Related Medical Devices Stocks
Abbott Laboratories
$187.45B
MDTMedtronic plc.
$120.46B
SYKStryker Corporation
$116.27B
BSXBoston Scientific Corporation
$69.27B
EWEdwards Lifesciences Corporation
$51.82B
DXCMDexCom, Inc.
$33.17B
Popular Healthcare Stocks
Eli Lilly and Company
$1.02T
JNJJohnson & Johnson
$663.28B
ABBVAbbVie Inc.
$453.19B
MRKMerck & Co., Inc.
$370.89B
UNHUnitedHealth Group Incorporated
$356.47B











